Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00639587Phase 3Completed
A Phase 3 trial of cetirizine in perennial allergic rhinitis (PAR), sponsored by UCB. Started Aug 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00639587.